StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Geron's price to sales ratio was 61.2× on Jan 31, 2025, against 403.0× a year earlier. Over the last 5 years it ranged from 8.1× to 499.5×, with a median of 255.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 202561.2×−14.3
2024Dec 31, 202475.5×−378.8
2022Jul 29, 2022454.3×−45.2
2020Feb 28, 2020499.5×+116.3
2019Dec 31, 2019383.3×+190.9
2018Dec 31, 2018192.4×−103.6
2017Dec 29, 2017296.0×+243.3
2016Dec 30, 201652.7×+31.5
2015Dec 31, 201521.2×−375.7
2014Dec 31, 2014396.8×+49.7
2013Dec 31, 2013347.1×+268.6
2012Dec 31, 201278.5×−35.2
2011Jul 29, 2011113.8×–

More Geron figures

See a number that looks wrong?